Menu Menu


PRTG Financials       Clear


PRTG        0001095435    
Filing Date Form Type Description Document
2018-11-28 6-K REPORT OF FOREIGN ISSUER View Document
2018-11-21 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2018-10-11 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2018-08-28 6-K REPORT OF FOREIGN ISSUER View Document
2018-08-28 6-K REPORT OF FOREIGN ISSUER View Document
2018-08-14 6-K REPORT OF FOREIGN ISSUER View Document
2018-07-30 20-F ANNUAL REPORT View Document
2018-06-04 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2018-03-15 6-K REPORT OF FOREIGN ISSUER View Document
2018-03-15 6-K REPORT OF FOREIGN ISSUER View Document
2018-02-27 6-K REPORT OF FOREIGN ISSUER View Document
2018-02-05 6-K REPORT OF FOREIGN ISSUER View Document
2018-02-05 6-K REPORT OF FOREIGN ISSUER View Document
2018-01-25 4/A PRIMARY DOCUMENT View Document
2018-01-24 4 PRIMARY DOCUMENT View Document
2018-01-23 6-K REPORT OF FOREIGN ISSUER View Document
2018-01-11 4/A PRIMARY DOCUMENT View Document
2018-01-10 SC 13D SCHEDULE 13D View Document
2018-01-09 4 PRIMARY DOCUMENT View Document
2018-01-09 SC 13D/A AMENDMENT #1 View Document
2018-01-09 SC 13D/A AMENDMENT #1 View Document
2018-01-08 6-K REPORT OF FOREIGN ISSUER View Document
2018-01-05 4 PRIMARY DOCUMENT View Document
2018-01-04 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2018-01-04 4 PRIMARY DOCUMENT View Document
2017-12-04 SC 13D SCHEDULE 13D View Document
2017-12-04 SC 13D SCHEDULE 13D View Document
2017-12-04 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2017-11-20 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2017-11-09 6-K REPORT OF FOREIGN ISSUER View Document
2017-11-09 6-K REPORT OF FOREIGN ISSUER View Document
2017-11-09 6-K REPORT OF FOREIGN ISSUER View Document
2017-11-09 20-F/A AMENDMENT #1 View Document
2017-08-25 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2017-07-31 20-F ANNUAL REPORT View Document
2017-07-12 6-K PORTAGE ANNOUNCES RESULTS OF SHAREHOLDERS MEETING AND PROVIDES UPDATE ON ITS POR View Document
2017-05-17 6-K BIOHAVEN ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND FULL EXERCISE OF UNDER View Document
2017-05-10 6-K PORTAGE?S HOLDING IN BIOHAVEN View Document
2017-05-08 6-K BIOHAVEN ANNOUNCES PRICING OF ITS INITIAL PUBLIC OFFERING OF COMMON SHARES View Document
2017-05-03 3 FORM 3 SUBMISSION View Document
2017-04-12 6-K PORTAGE PROVIDES UPDATE ON ITS PORTFOLIO COMPANIES View Document
2017-04-10 6-K BIOHAVEN FILES REGISTRATION STATEMENT FOR PROPOSED PUBLIC OFFERING OF ITS COMMON View Document
2017-03-20 S-8 REGISTRATION STATEMENT View Document
2017-03-14 6-K BIOHAVEN CLOSES SECOND TRANCHE OF PRIVATE PLACEMENT AND APPOINTS TWO NEW DIRECTO View Document
2017-02-27 6-K REPORT OF FOREIGN PRIVATE ISSUER View Document
2016-12-09 6-K BIOHAVEN? BHV-0223 IS GRANTED ORPHAN DRUG DESIGNATION IN THE TREATMENT OF AMYOTR View Document
2016-11-30 6-K PORTAGE ANNOUNCES SPIN-OUT OF EYGEN LIMITED View Document
2016-11-28 6-K INTERIM FINANCIALS FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2016 View Document
2016-11-03 6-K BIOHAVEN RAISES $80 MILLION View Document
2016-09-21 6-K CHAIRMAN'S LETTER TO SHAREHOLDERS View Document
2016-08-30 6-K CONSOLIDATED INTERIM FINANCIALS FOR THE THREE MONTHS ENDED JUNE 30, 2016 AND MAN View Document
2016-08-05 6-K PORTAGE APPOINTS A NEW DIRECTOR View Document
2016-07-29 20-F ANNUAL REPORT View Document
2016-07-21 6-K View Document
2016-07-07 6-K FDA CLEARS BIOHAVEN'S IND FOR BHV-4157 ANS PORTAGE TO HOLD INVESTOR CONFERENCE C View Document
2016-05-26 6-K PORTAGE ANNOUNCES ORPHAN DRUG DESIGNATION REQUEST GRANTED FTO BIOHAVEN FOR BHV 4 View Document
2016-04-27 6-K BIOHAVEN APPOINTS CHIEF COMMERCIAL OFFICER View Document
2016-04-07 6-K PORTAGE PROVIDES CORPORATE UPDATES View Document
2016-03-23 6-K PORTAGE INVESTS FURTHER IN BIOHAVEN View Document
2016-03-21 6-K ORPHAN DRUG DESIGNATION RECEIVED BY BIOHAVEN View Document
2016-03-14 6-K ANNOUNCEMENT OF PROPOSED PRIVATE PLACEMENT View Document
2016-02-26 6-K THIRD QUARTER 16 FINANCIALS AND MDA View Document
2016-02-25 6-K EXPEDITED DEVELOPMENT PATH FOR BHV 0223 FOR BIOHAVEN View Document
2016-02-25 6-K POSITIVE RESULTS FROM PHASE 1 STUDY WITH BHV-0223 View Document
2016-02-08 6-K NOTICE OF RECORD AND MAILING DATE View Document
2016-01-25 6-K PORTAGE PROVIDES PPL UPDATES View Document
2015-12-01 6-K INTERIM FINANCIALS FOR THE SIX MONTHS ENDED SEPT 30, 2015 View Document
2015-11-23 6-K BIOHAVEN PHASE 1 TRIALS View Document
2015-10-06 6-K BIOHAVEN COMPLETES MULTIPLE DOSING IN PHASE ONE TRIAL View Document
2015-10-02 6-K STRATEGIC ALLIANCE WITH FOX CHASE CHEMICAL View Document
2015-09-21 6-K BIOHAVEN COMPLETES SINGLE DOSE PHASE View Document
2015-09-21 6-K PORTAGE ISSUES LETTER TO SHAREHOLDERS View Document
2015-08-31 6-K PPL ADVANCES ITS PPL-003 TO AN IND View Document
2015-08-27 6-K BIOHAVEN DOSES FIRST HUMAN SUBJECT IN PHASE 1 TRIAL View Document
2015-08-26 6-K QUARTERLY FINANCIALS AND MDA 6.30.2015 View Document
2015-08-25 6-K PORTAGE BIOHAVEN INDA GETS CLEARANCE FORM FDA View Document
2015-08-21 6-K BIOHAVEN ACQUIRES NEW IPS View Document
2015-08-11 6-K BIOHAVEN RAISES $4.1 View Document
2015-08-11 6-K PORATGE INVESTS IN SENTIEN View Document
2015-07-30 20-F ANNUAL REPORT View Document
2015-07-23 6-K PORTAGE'S BIOHAVEN FILES AN INDA View Document
2015-06-25 6-K COMPLETION OF PRIVATE PLACEMENT View Document
2015-06-17 6-K PORTAGE CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT View Document
2015-05-19 6-K PROPOSED PRIVATE PLACEMENT View Document
2015-04-22 6-K BIOHAVEN UPDATE View Document
2015-04-21 6-K PPL UPDATE View Document
2015-04-16 6-K PORTAGE ATTENDING INVESTOR MASTER SHOW IN UK View Document
2015-04-01 6-K BIOHAVEN UPDATE RE INVENTIV View Document
2015-03-25 6-K BIOHAVEN UPDATE View Document
2015-03-17 S-8 2013 OPTION PLAN REGISTRATION View Document
2015-02-18 6-K FINANCIALSTATEMENTSFEB15 View Document
2015-02-12 SC 13D/A SC 13D/A View Document
2014-12-18 6-K BIOHAVEN UPDATE View Document
2014-12-16 6-K PPL UPDATE View Document
2014-11-28 6-K PORTAGEFINANCIALS2Q15 View Document
2014-10-16 6-K CLOSURE OF PRIVATE PLACEMENT View Document
2014-10-08 6-K APPOINTMENT OF ADDITIONAL CONSULTANTS View Document
2014-09-29 6-K CONVERSION OF DEBTS INTO EQUITY View Document
2014-09-24 6-K PORTAGE APPOINTS NEW CONSULTANTS View Document
2014-08-13 6-K QUARTERLY FINANCIALS View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.